Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Thyroid Eye Disease Charitable TrustTEDct c/o Miss Rebecca Ford
Bristol Eye Hospital
Lower Maudlin Street
Bristol, United Kingdom
Email Phone Web
Thyroid Eye Disease Charitable Trust (TEDct) provides information, care and support to those affected by Thyroid Eye Disease (TED). TEDct was founded in 1990 and gained charitable trust status in 2002. It aims not only to create greater awareness of thyroid eye disease, but also to inform and support those affected by the disease.
TEDct provides the opportunity for those affected by TED to receive support and all of the latest medical information from our newsletter, Q&As and other resources. We organise patient information meetings and fundraising events, and also participate in appropriate medical conferences.
TEDct is run entirely by volunteers. About half of our volunteers are medical professionals, from endocrinologists, to oculo-plastic surgeons, ophthalmic surgeons, and research scientists. The rest of our volunteers are people whose lives have been affected by TED, both directly and indirectly.
Endocrine SocietyEndocrine Society is the world's oldest,...
Clinical Implications of Immunoglobulin G4 to Graves’ OphthalmopathyBackground: This study aimed to explore...
Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active ...Horizon Pharma plc today announced topli...
Manejo Quirúrgico de la Enfermedad de Graves• La tiroidectomía puede considerarse...
Charles Sydnor, MDCharles Sydnor began his private ophthal...
Total Thyroidectomy (Tx) Versus Thionamides (Antithyroid Drugs) in Patients With Moderate-to-Severe Graves’ Op...Background: Graves' disease (GD) is cha...
Eyes on Graves’: LaQuilla’s Storyhttps://www.youtube.com/watch?v=98tJEN1C...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.